INTRODUCTION
The man of 21st century is breathing under various adversities, stresses, strains and anxiety. The everchanging modes of livelihood force one to continuously update oneself in every respect to performs functions such as protection of the body against physical, chemical, mechanical and biological injuries, thermoregulation etc. Besides all this it plays an important role in the expression of beauty, leaving impression.
The skin has long been recognized as the 'organ of expression' and serves as the boundary between ourselves and the outside world. Dermatological disorders have an immediate impact on tactile communication and bodily interaction. So one of the baffling problems of mankind since time immemorial is the skin disease, which manifest in variety of forms. Shvitra is mentioned along with other types of Kushtha, but the difference between Shvitra and Kushtha is based on non-secretary and non-infectious nature of disease, involvement of Twaka only, peculiarity of Nidana, Asadhya Lakshana and chronicity. According to modern dermatology, Shvitra can be correlated with Vitiligo and Leucoderma. There are several diseases marked by a lack of pigment in the skin that are grossly referred to as Leucoderma; some are caused by an inability of melanocytes to produce melanin, while others are caused by melanocytes either not being present or being destroyed. Vitiligo is a progressive disease in which the melanocytes are gradually destroyed causing unpigmented areas on the skin.
Many times common causes are observed as severe emotional stresses, (in some countries) social and emotional discrimination etc. Vitiligo may be become; a psychologically devastating disorder when it typically occurs in exposed areas (face and hands). According to the modern line of treatment PUVA (Psoralen + Ultra violet A) remains the therapy of choice along with the corticosteroid therapy, vitamin B12, folic acid, pseudocatalase, antioxidant, MSH analogues, khellin, calcium etc. PUVA has several adverse effects, so It is also time consuming and carries certain health risk for both patient and physician. Therefore it's a time need look for harmless and as well as effective treatment in the Ayurveda. Acharya Charaka has mentioned that Samshamana therapy can be administered to patient after Shodhana therapy in this disease.
[1] Because of the chronic and relapsing nature of the disease radical therapies like Shodhana should be undertaken for long lasting relief. Sodhana essentially refers to biopurification of the body aiming to cleanse the macro and micro channels of the biological system-Srotas. Therefore, on the basis of classical references in the present study Vamana Karma and Virechana Karma, [2] Darvigomootra Ghanavati [3] and Apamarga Kshara Lepa [4] has been selected in the treatment of Shvitra (Vitiligo).
OBJECTIVES
To evaluate and compare the efficacy of the Vamana and Virechana Karma in the management of the Shvitra (Vitiligo) and also to evaluate the clinical efficacy of Darvigomootra Ghanavati and Apamarga Kshara Lepa in the management of the Shvitra (Vitiligo).
MATERIALS AND METHODS
Patients having sign and symptoms of Shvitra (Vitiligo) were selected for present studies. Patients fulfilling the criteria and attending OPD and IPD of Dept. of Panchakarma, and cases referred by other Departments of I.P.G.T. & R.A. Hospital, G.A.U. Jamnagar, were selected randomly irrespective of race, cast, sex, religion etc.
The study was carried out after obtaining permission from institutional ethics committee. Inform concert (IC) of patients was taken prior to clinical study. After ethical clearance of the synopsis, study was registered in CTRI with registration no CTRI/2014/09/005004.
Inclusion Criteria
Patients having sign and symptoms of Shvitra (Vitiligo)
Patients between age group of 15 years to 50 years were selected.
Patients having chronicity less than 10 yrs.
Exclusion Criteria
Patients complicated with any cardiovascular diseases, renal diseases, hepatic disease, carcinoma, major illness like IDDM, NIDDM, patches due to burning, chemical explosion, any other serious systematic illness or any other disease effecting multiple body systems and pregnant women etc.
Patients contraindicated for Vamana and Virechana Karma as per classics.
Study Design
Randomised clinical trial, Interventional. Patients were allocated by using lottery randomisation method.
Grouping
In the present study 3 groups were done.
Group A -In this group classical Vamana Karma was given. Followed by oral administration of Darvigomootra Ghaanavati 6g/day with the Apamargakshara Lepa for duration of 8 weeks.
Group B -In this group classical Virechana Karma was given. Followed by oral administration of Darvigomootra Ghanavati 6g/day with the Apamargakshara Lepa for duration of 8 weeks.
Group C -Oral administration of Darvigomootra Ghanavati 6g/day with the Apamargakshara Lepa for duration of 8 weeks.
Darvigomootra Ghanavati
Prepared with Darvi (Berberis Aristata) and Gomootra (Cow Urine) by the classical method of Ghana Kriya.
Apamargkshara Lepa
Prepared with Apamarga Kshara and Gomootra.
Advice
All subjects were explained the Pathyapathya of Shvitra (Vitiligo). Nature of the diseases was explained and reassurance was given to all the subjects belonging to groups.
Assessment
There is acurrent lack of consensus on methods of assessment of this disorder, which makes it generally impossible to perform meta-analyses or compare the outcomes of different studies of the same treatment or parameter. Recently, the Vitiligo Area Scoring Index (VASI) tools was proposed to offer more accurate measures of disease severity indexes and treatment evaluation criteria compared to simple clinical photography alone. VASI provides a relatively simple method, analogous to the Psoriasis Area Severity Index (PASI), to measure repigmentation. With the VASI score difference of color of the patch was analysis. On the basis of VASI score and color of the patch overall assessment was analyzed.
Criteria for the assessment of overall effect of the therapies
For this purpose, following categories were maintained.
Worsened: Disease condition worsen with the increases in VASI Score.
Unchanged:
No changes in VASI score and color of the patches.
Mild improvement: Below 25% improvement in VASI score and color of the patches.
Moderate improvement: 26%-50 % improvement in VASI score and color of the patches.
Marked improvement: 51%-75% improvement in VASI score and color of the patches.
Complete remission: 76%-100% improvement in VASI score and color of the patches. 75% of the patients had white coloured patches of skin observed and 13.04% of the patients had red to whitish coloured patches of skin observed.
OBSERVATION
44.57% of the patients had more than 4 patches, 18.48% had 2 and 3 patches respectively, 66.30% of the patients had involved 1 percentage areas of the body while 15.22% had more than 4 percentage areas involved, 53.26% of the patients had more than 4cm size of patches. 
RESULTS
In Group A the initial mean score of VASI of patches was 2.35 which got reduced up to 2.30 and relief was by 2.16% which was statistically highly significant (p<0.0001). In Group B the initial mean score was 1.02 which has been reduced to 0.97 by 4.61% relief and the result was statistically highly significant (p<0.0001). In Group C the initial mean score was 0.866 which has been reduced to 0.863 by 0.38% relief and the result was statistically insignificant (p<0.0001).
In Group A the initial mean score of color of patches was 4.32 which got reduced up to 3.71 and relief was by 14.32% which was statistically highly significant (p<0.001). In Group B the initial mean score was 4.87 which has been reduced to 4.13 by 15.07% relief and the result was statistically highly significant (p<0.001).
While in Group C the initial mean score was 4.55 which has been reduced to 4.07 by 10.60% relief and the result was statistically highly significant (p<0.001). B-C 4.99 >0.05 *= significant, **= highly significant, ***= highly highly significant
DISCUSSION
According to modern science it may appear at any age cases have been reported as early as 6 weeks after birth and after 80 years of age.
[5] Ayurvedic texts have told Shvitra as Pittapradhana Tridoshaja Vyadhi. This is evident from above data as Shvitra is more prevalent in age group which was Pitta Pradhana. [6] According to modern science male and female both 
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are equally affected from this disease. [7] So the observed findings are due to smaller sample size or female ratio is more than male may be due to female is more conscious than male about cosmetic values.
Percentage improvement in color of patches of both (Vamana and Virechana) Shodhana therapy show better improvement than Shamana therapy. In the classical texts they mentioned that through Virechana one can get Varna Shuddhi, [8] so here Virechana
Group shows better result in colour of the patches than other groups. However in comparison there is no statistically significant (p>0.05) difference was found between three therapies in the improvement of colour of patches.
On effect of VAS Score comparison between the groups, statistically highly significant difference was seen between groups B and C and in groups A and C statistically significant difference was found. However between group A and B no significant (p>0.05) difference was noted. It means Group A and Group B which is Shodhana therapy shows the better result in VASI score than Shamana. However in the comparison of Shodhana therapy no significant difference was found which means any kind of Shodhana either Vamana or Virechan plays a key role in the management of Shvitra. (Table 1) VASI score is used for main assessment of pigmentation on the skin. In classical texts skin is mentioned as one of the Indriya. During the description of the benefits of both Vamana and Virechana Karma our Acharyas mentioned that both Karma make Indriya Shuddhi, [9] ,[10] that's why both Shodhana therapies show better result than Shamana therapy. In comparison between Vamana and Virechana groups; Virechana group shows better result, it may be due to significant changes were found in Raktavahasrotodusti through Virechana [11] and Rakta is mentioned as one of main Dushya of Shvitra.
[12]
Overall effect of therapy 
CONCLUSION
The result of both Shodhana therapies were statistically highly significant, though no significant difference was found between Vamana and Virechana therapy. Virechana group provided marked improvement and it is easy to perform with less complication and it emphasizes the importance of Shodhana in Shvitra. Result in color of patches
